0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Vermox Market Research Report 2025
Published Date: July 2025
|
Report Code: QYRE-Auto-2K6200
Home | Market Reports | Health| Pharmacy
Global Vermox Market Insights Forecast to 2028
BUY CHAPTERS

Global Vermox Market Research Report 2025

Code: QYRE-Auto-2K6200
Report
July 2025
Pages:73
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Vermox Market

The global market for Vermox was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Vermox is a brand name for the medication mebendazole. It is an anthelmintic drug used to treat various types of parasitic worm infections in the human body, such as pinworm, roundworm, and hookworm infections. Mebendazole works by disrupting the parasites" ability to absorb nutrients, eventually leading to their death. It is commonly used to treat intestinal worm infections, especially in children, and helps alleviate symptoms like itching, abdominal discomfort, and gastrointestinal issues caused by these parasites.
North American market for Vermox is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Vermox is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Vermox in Children is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Vermox include Johnson & Johnson, Amneal Pharmaceuticals, Cadila Pharmaceuticals, Eipico, Esteve Pharmaceuticals, Tenry, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Vermox, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Vermox.
The Vermox market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Vermox market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Vermox companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Vermox Market Report

Report Metric Details
Report Name Vermox Market
Segment by Type
  • Tablet
  • Oral Suspension
Segment by Application
  • Children
  • Adult
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Johnson & Johnson, Amneal Pharmaceuticals, Cadila Pharmaceuticals, Eipico, Esteve Pharmaceuticals, Tenry
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Vermox company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Vermox Market report?

Ans: The main players in the Vermox Market are Johnson & Johnson, Amneal Pharmaceuticals, Cadila Pharmaceuticals, Eipico, Esteve Pharmaceuticals, Tenry

What are the Application segmentation covered in the Vermox Market report?

Ans: The Applications covered in the Vermox Market report are Children, Adult

What are the Type segmentation covered in the Vermox Market report?

Ans: The Types covered in the Vermox Market report are Tablet, Oral Suspension

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Vermox Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Tablet
1.2.3 Oral Suspension
1.3 Market by Application
1.3.1 Global Vermox Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Children
1.3.3 Adult
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Vermox Market Perspective (2020-2031)
2.2 Global Vermox Growth Trends by Region
2.2.1 Global Vermox Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Vermox Historic Market Size by Region (2020-2025)
2.2.3 Vermox Forecasted Market Size by Region (2026-2031)
2.3 Vermox Market Dynamics
2.3.1 Vermox Industry Trends
2.3.2 Vermox Market Drivers
2.3.3 Vermox Market Challenges
2.3.4 Vermox Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Vermox Players by Revenue
3.1.1 Global Top Vermox Players by Revenue (2020-2025)
3.1.2 Global Vermox Revenue Market Share by Players (2020-2025)
3.2 Global Vermox Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Vermox Revenue
3.4 Global Vermox Market Concentration Ratio
3.4.1 Global Vermox Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Vermox Revenue in 2024
3.5 Global Key Players of Vermox Head office and Area Served
3.6 Global Key Players of Vermox, Product and Application
3.7 Global Key Players of Vermox, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Vermox Breakdown Data by Type
4.1 Global Vermox Historic Market Size by Type (2020-2025)
4.2 Global Vermox Forecasted Market Size by Type (2026-2031)
5 Vermox Breakdown Data by Application
5.1 Global Vermox Historic Market Size by Application (2020-2025)
5.2 Global Vermox Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Vermox Market Size (2020-2031)
6.2 North America Vermox Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Vermox Market Size by Country (2020-2025)
6.4 North America Vermox Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Vermox Market Size (2020-2031)
7.2 Europe Vermox Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Vermox Market Size by Country (2020-2025)
7.4 Europe Vermox Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Vermox Market Size (2020-2031)
8.2 Asia-Pacific Vermox Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Vermox Market Size by Region (2020-2025)
8.4 Asia-Pacific Vermox Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Vermox Market Size (2020-2031)
9.2 Latin America Vermox Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Vermox Market Size by Country (2020-2025)
9.4 Latin America Vermox Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Vermox Market Size (2020-2031)
10.2 Middle East & Africa Vermox Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Vermox Market Size by Country (2020-2025)
10.4 Middle East & Africa Vermox Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Johnson & Johnson
11.1.1 Johnson & Johnson Company Details
11.1.2 Johnson & Johnson Business Overview
11.1.3 Johnson & Johnson Vermox Introduction
11.1.4 Johnson & Johnson Revenue in Vermox Business (2020-2025)
11.1.5 Johnson & Johnson Recent Development
11.2 Amneal Pharmaceuticals
11.2.1 Amneal Pharmaceuticals Company Details
11.2.2 Amneal Pharmaceuticals Business Overview
11.2.3 Amneal Pharmaceuticals Vermox Introduction
11.2.4 Amneal Pharmaceuticals Revenue in Vermox Business (2020-2025)
11.2.5 Amneal Pharmaceuticals Recent Development
11.3 Cadila Pharmaceuticals
11.3.1 Cadila Pharmaceuticals Company Details
11.3.2 Cadila Pharmaceuticals Business Overview
11.3.3 Cadila Pharmaceuticals Vermox Introduction
11.3.4 Cadila Pharmaceuticals Revenue in Vermox Business (2020-2025)
11.3.5 Cadila Pharmaceuticals Recent Development
11.4 Eipico
11.4.1 Eipico Company Details
11.4.2 Eipico Business Overview
11.4.3 Eipico Vermox Introduction
11.4.4 Eipico Revenue in Vermox Business (2020-2025)
11.4.5 Eipico Recent Development
11.5 Esteve Pharmaceuticals
11.5.1 Esteve Pharmaceuticals Company Details
11.5.2 Esteve Pharmaceuticals Business Overview
11.5.3 Esteve Pharmaceuticals Vermox Introduction
11.5.4 Esteve Pharmaceuticals Revenue in Vermox Business (2020-2025)
11.5.5 Esteve Pharmaceuticals Recent Development
11.6 Tenry
11.6.1 Tenry Company Details
11.6.2 Tenry Business Overview
11.6.3 Tenry Vermox Introduction
11.6.4 Tenry Revenue in Vermox Business (2020-2025)
11.6.5 Tenry Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
 Table 1. Global Vermox Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Tablet
 Table 3. Key Players of Oral Suspension
 Table 4. Global Vermox Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 5. Global Vermox Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 6. Global Vermox Market Size by Region (2020-2025) & (US$ Million)
 Table 7. Global Vermox Market Share by Region (2020-2025)
 Table 8. Global Vermox Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 9. Global Vermox Market Share by Region (2026-2031)
 Table 10. Vermox Market Trends
 Table 11. Vermox Market Drivers
 Table 12. Vermox Market Challenges
 Table 13. Vermox Market Restraints
 Table 14. Global Vermox Revenue by Players (2020-2025) & (US$ Million)
 Table 15. Global Vermox Market Share by Players (2020-2025)
 Table 16. Global Top Vermox Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Vermox as of 2024)
 Table 17. Ranking of Global Top Vermox Companies by Revenue (US$ Million) in 2024
 Table 18. Global 5 Largest Players Market Share by Vermox Revenue (CR5 and HHI) & (2020-2025)
 Table 19. Global Key Players of Vermox, Headquarters and Area Served
 Table 20. Global Key Players of Vermox, Product and Application
 Table 21. Global Key Players of Vermox, Date of Enter into This Industry
 Table 22. Mergers & Acquisitions, Expansion Plans
 Table 23. Global Vermox Market Size by Type (2020-2025) & (US$ Million)
 Table 24. Global Vermox Revenue Market Share by Type (2020-2025)
 Table 25. Global Vermox Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 26. Global Vermox Revenue Market Share by Type (2026-2031)
 Table 27. Global Vermox Market Size by Application (2020-2025) & (US$ Million)
 Table 28. Global Vermox Revenue Market Share by Application (2020-2025)
 Table 29. Global Vermox Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 30. Global Vermox Revenue Market Share by Application (2026-2031)
 Table 31. North America Vermox Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 32. North America Vermox Market Size by Country (2020-2025) & (US$ Million)
 Table 33. North America Vermox Market Size by Country (2026-2031) & (US$ Million)
 Table 34. Europe Vermox Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 35. Europe Vermox Market Size by Country (2020-2025) & (US$ Million)
 Table 36. Europe Vermox Market Size by Country (2026-2031) & (US$ Million)
 Table 37. Asia-Pacific Vermox Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 38. Asia-Pacific Vermox Market Size by Region (2020-2025) & (US$ Million)
 Table 39. Asia-Pacific Vermox Market Size by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Vermox Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 41. Latin America Vermox Market Size by Country (2020-2025) & (US$ Million)
 Table 42. Latin America Vermox Market Size by Country (2026-2031) & (US$ Million)
 Table 43. Middle East & Africa Vermox Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 44. Middle East & Africa Vermox Market Size by Country (2020-2025) & (US$ Million)
 Table 45. Middle East & Africa Vermox Market Size by Country (2026-2031) & (US$ Million)
 Table 46. Johnson & Johnson Company Details
 Table 47. Johnson & Johnson Business Overview
 Table 48. Johnson & Johnson Vermox Product
 Table 49. Johnson & Johnson Revenue in Vermox Business (2020-2025) & (US$ Million)
 Table 50. Johnson & Johnson Recent Development
 Table 51. Amneal Pharmaceuticals Company Details
 Table 52. Amneal Pharmaceuticals Business Overview
 Table 53. Amneal Pharmaceuticals Vermox Product
 Table 54. Amneal Pharmaceuticals Revenue in Vermox Business (2020-2025) & (US$ Million)
 Table 55. Amneal Pharmaceuticals Recent Development
 Table 56. Cadila Pharmaceuticals Company Details
 Table 57. Cadila Pharmaceuticals Business Overview
 Table 58. Cadila Pharmaceuticals Vermox Product
 Table 59. Cadila Pharmaceuticals Revenue in Vermox Business (2020-2025) & (US$ Million)
 Table 60. Cadila Pharmaceuticals Recent Development
 Table 61. Eipico Company Details
 Table 62. Eipico Business Overview
 Table 63. Eipico Vermox Product
 Table 64. Eipico Revenue in Vermox Business (2020-2025) & (US$ Million)
 Table 65. Eipico Recent Development
 Table 66. Esteve Pharmaceuticals Company Details
 Table 67. Esteve Pharmaceuticals Business Overview
 Table 68. Esteve Pharmaceuticals Vermox Product
 Table 69. Esteve Pharmaceuticals Revenue in Vermox Business (2020-2025) & (US$ Million)
 Table 70. Esteve Pharmaceuticals Recent Development
 Table 71. Tenry Company Details
 Table 72. Tenry Business Overview
 Table 73. Tenry Vermox Product
 Table 74. Tenry Revenue in Vermox Business (2020-2025) & (US$ Million)
 Table 75. Tenry Recent Development
 Table 76. Research Programs/Design for This Report
 Table 77. Key Data Information from Secondary Sources
 Table 78. Key Data Information from Primary Sources
 Table 79. Authors List of This Report


List of Figures
 Figure 1. Vermox Picture
 Figure 2. Global Vermox Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Vermox Market Share by Type: 2024 VS 2031
 Figure 4. Tablet Features
 Figure 5. Oral Suspension Features
 Figure 6. Global Vermox Market Size by Application (2020-2031) & (US$ Million)
 Figure 7. Global Vermox Market Share by Application: 2024 VS 2031
 Figure 8. Children Case Studies
 Figure 9. Adult Case Studies
 Figure 10. Vermox Report Years Considered
 Figure 11. Global Vermox Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 12. Global Vermox Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 13. Global Vermox Market Share by Region: 2024 VS 2031
 Figure 14. Global Vermox Market Share by Players in 2024
 Figure 15. Global Top Vermox Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Vermox as of 2024)
 Figure 16. The Top 10 and 5 Players Market Share by Vermox Revenue in 2024
 Figure 17. North America Vermox Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 18. North America Vermox Market Share by Country (2020-2031)
 Figure 19. United States Vermox Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 20. Canada Vermox Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 21. Europe Vermox Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 22. Europe Vermox Market Share by Country (2020-2031)
 Figure 23. Germany Vermox Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 24. France Vermox Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 25. U.K. Vermox Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 26. Italy Vermox Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. Russia Vermox Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. Nordic Countries Vermox Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. Asia-Pacific Vermox Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Asia-Pacific Vermox Market Share by Region (2020-2031)
 Figure 31. China Vermox Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. Japan Vermox Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. South Korea Vermox Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. Southeast Asia Vermox Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. India Vermox Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. Australia Vermox Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. Latin America Vermox Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. Latin America Vermox Market Share by Country (2020-2031)
 Figure 39. Mexico Vermox Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. Brazil Vermox Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. Middle East & Africa Vermox Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. Middle East & Africa Vermox Market Share by Country (2020-2031)
 Figure 43. Turkey Vermox Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. Saudi Arabia Vermox Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 45. UAE Vermox Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 46. Johnson & Johnson Revenue Growth Rate in Vermox Business (2020-2025)
 Figure 47. Amneal Pharmaceuticals Revenue Growth Rate in Vermox Business (2020-2025)
 Figure 48. Cadila Pharmaceuticals Revenue Growth Rate in Vermox Business (2020-2025)
 Figure 49. Eipico Revenue Growth Rate in Vermox Business (2020-2025)
 Figure 50. Esteve Pharmaceuticals Revenue Growth Rate in Vermox Business (2020-2025)
 Figure 51. Tenry Revenue Growth Rate in Vermox Business (2020-2025)
 Figure 52. Bottom-up and Top-down Approaches for This Report
 Figure 53. Data Triangulation
 Figure 54. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Seventh Sense AI

RELATED REPORTS

Global GLP-1 Targeted Peptide Weight Loss Drugs Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-19A18322
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Stimulant-Free Fat Burners Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-3E3525
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Test Boosters Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-35T3049
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Salsalate Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-33Y1801
Thu Sep 11 00:00:00 UTC 2025

Add to Cart